Class II · Moderate risk Ongoing
Bisoprolol Fumarate and Hydrochlorothiazide tablets
Reason cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
Maxzide-25
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Superpotent Drug: Composite assay results obtained during routine stability testing were slightly above specification.
What was recalled
Maxzide-25 (Triamterene and hydrochlorothiazide) tablets, USP, 37.5 mg/ 25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-0464-01
- Recalling firm
- Mylan Pharmaceuticals Inc.
- NDC code
- 0378-0464-01
- Origin
- WV, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-0877-2018
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Hydrochlorothiazide recalls
See all
Class III · Low risk Ongoing
Bisoprolol Fumarate and Hydrochlorothiazide Tablets
Reason Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe
Class II · Moderate risk Ongoing
Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg
Reason Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.
Class II · Moderate risk Ongoing
Losartan Potassium and Hydrochlorothiazide Tablets
Reason Presence of foreign substance: plastic-like substance.
Class III · Low risk Terminated
Bisoprolol Fumarate and Hydrochlorothiazide Tablets
Reason Failed Impurities/Degradation Specifications
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.